CLADE AG

CLADE revolutionizes bioanalytics with a technology that analyzes liquids in minutes instead of hours or weeks. This innovation is based on proprietary mid-infrared (MIR) spectroscopy and advanced software and algorithms that enable comprehensive analysis without specific prior knowledge. For example: If you want to know the caffeine concentration in a cup of coffee using classic methods, you would have to send a sample to the laboratory and wait several hours for the result. If you also want to know the glucose content, a further analysis would be necessary. CLADE, on the other hand, takes a single sample and creates a digital twin of the liquid in around four minutes. This digital twin contains all the ingredients, which can then be analyzed using specific algorithms. This enables fast and precise determination and quantification of different substances such as caffeine or glucose from the same sample.

Since its foundation in 2001, then under the name micro-biolytics GmbH, CLADE has continuously developed this technology with over 60 experts at locations in Esslingen, Frankfurt and Berlin. The company supports the biopharmaceutical and chemical industries worldwide in the quality control of everything from basic chemicals to biopharmaceutical products.